ETF - Go long on ULTRA NASDAQ BIOTECHNOLOGY ($BIB)ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
BIB
$IWM RTY would be in trouble below 2100$IWM RTY would be in trouble below 2100
This week is a good week to play short if the momentum on the small cap index sells to the downside.
VBIV day trade [Price Target: $1.60]IFFFFF the $1.98 - $2.00 support line holds and buying pressure increases, I expect to see a pretty big upward price movement for the day. Remember folks, just ideas!
Biotech looks encouraging to me Looks sort of like a drunken cup with handle. Could use the current short tern uptrend line or recent weekly low as a stop. Process your way. Feedback appreciated.
NASDAQ AND S&P BIOTECH WITH HUGE BULLISH BREAKOUTSTextbook chart of an ending bottom and new uptrend starting. I don't want to miss out on this one, this could easily become the trade of the year.
The breakout is now confirmed, but i want to wait for a nice correction before entering.
S&P Biotech:
Blessings to you all.
XBI: Biotech slide back to channel bottom until End-JulyXBI, LABU, BIB should slide to the bottom of the channel until End-July. See high moving-average divergence, reconvergence and channel pattern. Short unless something changes.
LABUThe stock market was hit hard on the BREXIT vote. I believe LABU has now found a bottom. The LABU ETF shows a trend line break and a double bottom. The double bottom seems to be holding. Set your stops there. %R is over sold and recovering. Last time we saw this we had a run to the upper trend line. A similar move this time will bring us to $42. A very nice return on our $$$ risk if we get it. The purple arrows seem to confirm a trend change they are pointing out the Stochastic go long alerts. Same as before.
XBI great short - My favorite lately REJECT at 200 D SMAHas been supported by markets but not for long. check out 200 day ma..
XBI - At Very Critical PointXBI below every major MA except 100 SMA and this lies on an important point in the Kumo. IMO if this breaks and sell off starts, it could impact the entire market.
!BIOTECH WARNING!Big short potential if IBB doesn't break back into the wedge tomorrow (2/11). Ill be looking to add more LABD by the end of the week if we don't see a bounce. This could be a big one!
IDRA PharmaIDRA Pharma with a deeply oversold RSI and a tag of the lower trend line, IDRA looks like a buy.
ETFs potential BUYS -XPH-EIDO-EUO-XBI-BIBFor Monday’s open, 5 ETF's are potential buys under my rules for Pullback Strategy. This strategy identifies oversold ETFs and takes advantage of the tendency for prices to revert to the mean in the short term.
The ETFs set up as potential buys for Monday are listed in the table below:
XPH -SPDR S&P Pharmaceuticals
EIDO - Indonesia Invstble Mkt Idx MSCI
EUO - Ultrashort Euro Proshares
XBI - SPDR S&P Biotech
BIB - Ultra Nasdaq Biotechnology Prosh
